study levamisole administration as a product concomitantly with standard antibiotic therapy has no immunostimulating effect on the basis of the lymphocyte subgroups ratios and the ability of phagycytosis measured.[10] In Chandra study, showed that deficiency of, BMY 7378 Fe, Zn, Vit B6, Vit A, Cu, Na and Vit D had long-term effect on CMI.[11] In a pilot study by Salehi, it was revealed that Vit A as a supplement therapy can reduce the late complications of bruceelosis such as relapse.[12] The main object of this study was comparison between the standard therapy of brucellosis with and without Vit A. == MATERIALS AND METHODS == In a research project with the number of 75,005, which was approved by the Ethics Committee of Isfahan University of medical sciences, a semiexperimental and prospective clinical trial study was done on 120 cases of brucellosis. were randomized. A total of 60 patients received streptomycin and Doxycycline as standard therapy for 6 weeks as well as others in addition to this Regimen received Vit A for about 4 weeks. == Results: == In the case group, only 1 1 case (1.6%) relapsed and in BMY 7378 the control group 8 (13.5%) with significant difference (P< 0.005) between two groups. Morbidity of disease was different between two groups. == Conclusion: == Vit A therapy in the patients with Brucellosis with may reduce the disease morbidity and rate of chronicity. Keywords:Brucellosis, immunity, vitamin A == INTRODUCTION == Brucellosis is one of the endemic diseases in Iran, especially in our city Isfahan. Unpasteurized dairy products are the main causes of transmission BMY 7378 to human also it is usually a zoonotic disease. It is a disease of animal (Zoonosis) that under certain circumstances can be transmitted to humans.[1] Although it occurs world-wide, brucellosis is more common in countries that do not have effective animal health program.[2,3] As one of the first bacteria to be weaponized,Brucellaremains a potential bioterrorism agent[4,5] and all confirmed cases should have epidemiologic evaluation.[6] Muscoloskeletal involvement is the main problem, morbidity, and debility frequently was seen in this disease. Spink reports 20% chronicity in about 2,000 cases of brucellosis which it elongates greater than 1 year.[7] Because cell mediated immunity (CMI) is the main defensive mechanism of body in this disease,[8] it's seems that immunodeficient and malnourished patient more susceptible to this form of disease. In Kurmanovaet al. study, a clinical trials, demonstrated that the use of Vitamin A (Vit A) in a dose of 33,000 IU thrice a day for 10-12 days during the complex treatment of patients with acute (36 persons) and sub-acute (57 persons) brucellosis lowered the average period of manifestation of the disease (clinical indicators)[9] because it formation of antibodies, the lymphocyte blast cell transformation, the total number and subpopulation of the active T-cells. In Dizeret al. study levamisole administration as a product concomitantly with standard antibiotic therapy has no immunostimulating effect on the basis of the lymphocyte subgroups ratios and the ability of phagycytosis measured.[10] In Chandra study, showed that deficiency of, Fe, Zn, Vit B6, Vit A, Cu, Na and Vit D had long-term effect on BMY 7378 CMI.[11] In a pilot study by Salehi, it was revealed that Vit A as a product therapy can reduce the late complications of bruceelosis such as relapse.[12] The main object of this study was comparison between the standard therapy of brucellosis with and without Vit A. == MATERIALS AND METHODS == In a research project with the number of 75,005, which was approved by the Ethics Committee of Isfahan University or college of medical sciences, a semiexperimental and prospective clinical trial study was carried out on 120 cases of brucellosis. Inclusion criteria were: Paperwork of positive serologic enzyme-linked immuno sorbent BMY 7378 assay (ELISA) test and then confirmation by standard tube agglutination test (STA). Exclusion criteria were patients < 8 years old, disorders of vision, ear and kidney and pregnant women. By random selection, 60 patients received standard treatment of brucellosis streptomycin 15 mg/kg/d and Doxycylin 100 mg twice daly for about 6 weeks and 25,000 unit Vit A daily for about 4 weeks (case group), and 60 patient received only standard therapy of Brucellosis (control group) all the patients were unaware about the received drugs. Patients in both groups PCDH8 were clinically followed and examined constantly and by filling the questionnaires based on subjective symptoms such as fever, chills, sweating, anorexia, arthralgia, myalgia, anorexia, and objective indicators such as fever and arthritis. Duration of subjective symptoms and sings, chronicity and relapses in both group compared for about 1 year [Physique 1]. == Physique 1. == Patients who entered the study, where devided in two study groups, followed up and analysed Results were analyzed by using the SPSS software version 20. == RESULTS == In both groups, 40 persons (66%) were men and 20 persons (34%) were women [Table 1]. == Table 1. == Brucellosis patient’s by sex and location Almost.
